Source:
World Health Organization (WHO) |
Coronavirus: Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries
The Global Fund commits an initial US$50 million to enable countries to purchase the new tests
A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fund; several rapid, point-of-care antigen tests are being assessed by WHO for…
